Company attributes
Venture Capital Firm attributes
Other attributes
NBGI Ventures is a venture capital firm in London that focuses on investing in medical technology companies. Founded 2001 in London, England, United Kingdom by Aris Constantinides and Spiros Trachanis, it invests in early stage ventures, late stage ventures, and private equity. Its portfolio companies include Quanta, EPIX Therapeutics, DYSIS Medical, SuperSonic Imagine, CellNovo, Estech, SuperSonic Imagine, Symetis, and Reverse Medical. As of March 2020, NBGI Ventures has made 19 investments. Their most recent investment was on November 3, 2014, when Quanta raised £27M. NBGI Ventures has had nine exits, the most notable of which include EOS Imaging, BONESUPPORT, and EPIX Therapeutics. The company has raised a single venture fund, NBGI Ventures French Fund I. This fund was announced on January 14, 2010 and raised a total of €100M.
